Urotherapy for patients with cancer
References (96)
- et al.
Tumor-associated antigens detected by autologous sera in urine of patients with solid neoplasms
J Surg Res
(1980) - et al.
Comparison of 15 monoclonal antibodies against tumor-associated antigens of transitional cell carcinoma of the human bladder
J Urol
(1991) - et al.
Gastric juice CEA levels: importance of age and gastric mucosal damage
Eur J Cancer Clin Oncol
(1986) - et al.
Cumulative effects of age and pathology on plasma carcinoembryonic antigen in an unselected elderly population
Eur J Cancer Clin Oncol
(1984) - et al.
Chemical structure of carcinoma ganglioside antigens defined by monoclonal antibody CA50 and some allied gangliosides of human pancreatic adenocarcinoma
Biochim Biophys Acta
(1985) - et al.
Significance of CD44 gene products for cancer diagnosis and disease evaluation
Lancet
(1992) - et al.
Cellular immunity against tumor specific antigens
Adv Cancer Res
(1969) - et al.
Cyclophosphamide potentiates the antitumor activity of v-p97NY
Cell Immunol
(1989) The regulation of immune responses to dietary protein antigens
Immunol Today
(1987)- et al.
The distinctive specificity of antigen-specific suppressor T cells
Immunol Today
(1991)
Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein
J Neuroimmunol
(1992)
Treatment of glomerulonephritis by antigen
Lancet
(1936)
Bladder substitution after pelvic evisceration
Surg Clin N Am
(1950)
Lymphoid depletion in ileal loops: mechanism and clinical implications
J Pediatr Surg
(1976)
Colonic neoplasms following ureterosigmoidostomy
J Urol
(1975)
Neoplasia at the site of ureterosigmoidostomy
J Urol
(1976)
Adenocarcinoma at the site of ureterosigmoidostomies for exstrophy of the bladder
J Pediatr Surg
(1978)
Immunological aspects of malignant disease
Lancet
(1967)
Immunotherapy and genitourinary neoplasia
Urol Clin N Am
(1980)
Causality, complementarity, evolution, and emergent properties
The concept of immunological surveillance
Prog Exp Tumor Res
(1970)
Cell-mediated reactivity to antigens shared by Moloney virus induced lymphoma cells (LSTRA) and cells from certain 3-methylcholanthrene induced mouse sarcomas
Int J Cancer
(1979)
Cell-mediated immunity against antigens common to tumor colonic carcinomas and fetal gut epithelium
Int J Cancer
(1970)
Immunological approach to tumor therapy: monoclonal antibodies, tumor vaccines, and anti-idiotypes
Human melanoma antigen AH is an autologous ganglioside related to GD2
J Exp Med
(1982)
Prognostic significance of urinary antigen analysis by enzyme-linked immunosorbant assay in melanoma patients
Diag Immunol
(1983)
Urinary prostate specific antigen levels: role in monitoring the response of prostate cancer to therapy
J Urol
(1992)
Monoclonal antibodies against gastro-interstinal tumor-associated antigens isolated as monosialogangliosides
Int Arch Allergy Appl Immun
(1983)
Detection by monoclonal antibody of carbohydrate antigen CA50 in serum of patients with carcinoma
Br Med J
(1984)
CA 19-9, CA50 and CEA bei Pankreas and gastrointestinal Tumoren
Medizin Klin
(1987)
CA 50 im serum von Karzinom-Patienten
Deutsch Med Wochenschr
(1986)
CA 50 determination in body fluids: can we screen patients at risk for gastric cancer?
Int J Cancer
(1991)
A soluble form of the adhesion receptor CD58 (LFA-3) is present in human body fluids
Eur J Immunol
(1993)
Urinary organ specific neoantigen. A potentially diagnostic test for colorectal cancer
Dig Dis Sci
(1995)
Evidence that an elevated level of ornithine decerboxylase activity is an essential component of tumor promotion
Adv Polyamine Res
(1983)
Urinary polyamine levels in patients with gastrointestinal malignancy
Cancer
(1975)
Polyamines in colorectal cancer. Evaluation of polyamine concentrations in the colon tissue, serum and urine of 50 patients with colorectal cancer
Cancer
(1990)
Non-invasive detection of malignancy by identification of unusual CD44 gene activity in exfoliated cancer cells
Br Med J
(1994)
Unusual retention of introns in CD44 gene transcripts in bladder cancer provides new diagnostic and clinical oncological opportunities
J Pathol
(1995)
Immunotherapy of cancer: regression of tumors after intralesional injection of living Mycobacterium bovis
Science
(1971)
Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report
N Engl J Med
(1988)
Tumors of the immunocompromised patient
Annu Rev Med
(1988)
Lysis of autologous tumor cells by blood lymphocytes activated in autologous mixed lymphocyte tumor cell culture — no correlation with the postsurgical clinical course
Cancer Immunol Immunother
(1987)
Specificity of auto-tumor cytotoxicity exerted by fresh, activated and propagated human T lymphocytes
Int J Cancer
(1982)
Cytolytic T cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection
A review of transfer factor immunotherapy in cancer
Cancer
(1974)
Osteogenic sarcoma. Immunologic parameters before and during immunotherapy with tumor-specific transfer factor
J Clin Invest
(1975)
Cited by (6)
Camel (Camelus spp.) Urine Bioactivity and Metabolome: A Systematic Review of Knowledge Gaps, Advances, and Directions for Future Research
2022, International Journal of Molecular SciencesZootherapeutic uses of animals excreta: the case of elephant dung and urine use in Sayaboury province, Laos
2021, Journal of Ethnobiology and EthnomedicineHuman urine-based therapeutics in Spain from the early 20<sup>th</sup> century to the present: A historical literature overview and a present-day case study
2017, AMHA - Acta Medico-Historica AdriaticaDermatological evaluation of counter irritant potential of Human urine in rabbits
2015, Journal of the Pakistan Medical AssociationWound healing activity of human urine in rats
2010, Research Journal of Pharmaceutical, Biological and Chemical Sciences
Copyright © 1997 Published by Elsevier Ltd.